The Hard Gelatin Capsules Market is expected to develop at a CAGR of 6.4% between 2022 and 2032. According to the analysis, the oral administration segment maintained a sizable market share in the worldwide industry, accounting for over 88.5% of the market value in 2021. Shell suppliers create and supply empty hard gelatin capsule shells …
Category Archives: Healthcare Trends
East Asia Knee Hyaluronic Acid Injections Market is set to exhibit a CAGR of 5.2% through 2031 | Owing to increase in hospitals and Ambulatory surgical centers
According to the most recent Future Market Insights (FMI) survey, the Knee Hyaluronic Acid Injections Market revenue will be $1.9 billion in 2021. Overall sales of knee hyaluronic acid injections are predicted to reach US$ 3.0 billion by 2031, expanding at a CAGR of more than 5.0% between 2021 and 2031. With surging awareness, the …
Revision Knee Replacement Market is expected to reach a valuation of US$ 2 billion by 2032 | FMI Report
Revision Knee Replacement Market is expected to reach US$ 1.3 billion by 2022. The revision knee replacement market is expected to reach US$ 2 billion by 2032, with a CAGR of 4.1%. Revision knee replacement also known as revision total knee arthroplasty, is a procedure in which already implanted artificial knee joint, or prosthesis is …
IgA Nephropathy Market is expected to grow at a 7.5% CAGR from 2023 to 2033 | FMI Analyst
According to Future Market Insights, the IgA Nephropathy Market is predicted to increase at a 7.5% CAGR between 2023 and 2033. By the year 2033, the global market for IgA nephropathy is predicted to reach a value of US$ 85 billion. Key factors such as the high frequency of renal illnesses, expanding R&D efforts, increased …
Fucosidosis Therapeutics Market is expected to grow with a 6% CAGR during 2023 to 2033 | FMI Report
The global Fucosidosis Therapeutics Market is expected to garner a market value of US$ 10 Million in 2023 and is expected to accumulate a market value of US$ 17.91 Million by registering a CAGR of 6% in the forecast period 2023 to 2033. The market for Fucosidosis Therapeutics registered a CAGR of 4% in the …
Magnetoencephalography Market is projected to increase at a CAGR of around 5.4% from 2023 to 2033 | FMI Analyst
The Magnetoencephalography Market revenues were estimated at US$ 273 Million in 2022 and are anticipated to grow at a CAGR of 5.4% from 2023 to 2033, according to a recently published Future Market Insights report. By the end of 2033, the market is expected to reach US$ 485.2 Million. MEG scanners have been found to …
Wilson’s Disease Diagnostics Market is expected to grow with a 3.9% CAGR during 2023 to 2033 | FMI Study
During the forecast period 2023 to 2033, Wilson’s Disease Diagnostics Market is expected to grow at a value of 3.9% CAGR, according to Future Market Insights. By the year 2033, the global market for Wilson’s disease diagnostics is expected to rise up to a market valuation of US$ 896 Million. The global market for Wilson’s …
Global Crohn’s Disease (CD) Treatment Market is expected to reach a valuation of US$ 17.8 billion by 2033; growing at a 4.3% CAGR | FMI Study
The global Crohn’s Disease (CD) Treatment Market is anticipated to be valued at US$ 11.68 billion by the end of 2023. According to Future Market Insights, the market will grow at a 4.3% CAGR from 2023 to 2033, reaching a market value of around US$ 17.8 billion by the end of 2033. The incidence of …
Lung Cancer to Procure 35% Oncolytic Adenovirus Market | FMI Study
During the forecast period 2023 to 2033, the oncolytic adenovirus market is expected to grow at a value of 7.5% CAGR, according to Future Market Insights. By the year 2033, the global market for oncolytic adenovirus is expected to rise up to a market valuation of US$ 250 Billion. Growth of the market can be …
Continue reading “Lung Cancer to Procure 35% Oncolytic Adenovirus Market | FMI Study”
According to Future Market Insights, the non-surgical segment by treatment type is predicted to acquire more than 50% global exophthalmos treatment market share in 2023.
In fiscal year 2023, the market for exophthalmos treatment is anticipated to be valued US$ 271.8 million, up from US$ 251.2 million in fiscal year 2022. The worldwide market is anticipated to increase steadily between 2023 and 2033, increasing its value to US$ 598 million by the end of that year. Graves’ illness is most …